Company news
SIGA Technologies Inc. news in 2024
SIGA Technologies Inc.'s news releases, calls and decks from 2024, newest first.
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
December 9, 2024
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024
November 6, 2024
SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results
October 30, 2024
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
October 21, 2024
SIGA Announces Agreement to Supply TPOXX® in Morocco
October 7, 2024
SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®
August 20, 2024
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released
August 14, 2024
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
July 31, 2024
SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results
July 24, 2024
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
July 18, 2024
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
June 16, 2024
SIGA Reports Financial Results for Three Months Ended March 31, 2024
May 6, 2024
SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
April 30, 2024
SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
March 31, 2024
SIGA Names Larry Miller General Counsel
March 24, 2024
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
March 11, 2024
SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
March 4, 2024
SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
January 21, 2024